Meng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Meng Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Yunxiu Wang
Department of Clinical Trial Ward, Clinical Trial and Conversion Center, Shengjing Hospital of China Medical University, Shenyang 110004, PR China; Department of Clinical Epidemiology, Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang 110004, PR China; Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, PR China
2 shared publications - Zhaowei Gu
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
2 shared publications - Zhiwei Cao
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
2 shared publications Guijie Yuan
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
1 shared publication- Jiani Li
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China
1 shared publication - Jing Yang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China
1 shared publication
Latest Publications
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.